# Niagen Bioscience, Inc.: filings

NAGE · Nasdaq · CIK 1386570 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nage.md) · [Financials](/companies/nage/financials.md) · [Filings](/companies/nage/filings.md) · [Insiders](/companies/nage/insiders.md)

## Reports and events: 366 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 322, 8-K 226, 10-Q 53, 3 38, SC 13D/A 36, CT ORDER 31, 10-K 18, DEF 14A 18, CORRESP 17, UPLOAD 16, D 15, EFFECT 15, 424B3 14, DEFA14A 14, S-3 12, SC 13G/A 12, S-8 10, 424B5 9, 4/A 9, SC 13G 9, 10-Q/A 5, ARS 5, PRE 14A 5, 10-K/A 3, SC 13D 3, 144 2, 3/A 2, NT 10-Q 2, S-1 2, S-3/A 2, 5 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, POS AM 1, S-1/A 1, S-8 POS 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 16:04 ET | [10-Q](/filings/0001386570-26-000043.md) | Quarterly report, period 2026-06-30 | 0001386570-26-000043 |
| 2026-08-04 | 16:03 ET | [8-K](/filings/0001386570-26-000042.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-26-000042 |
| 2026-06-29 | 16:30 ET | [8-K](/filings/0001386570-26-000035.md) | 5.07 Shareholder vote results | 0001386570-26-000035 |
| 2026-05-06 | 16:01 ET | [8-K](/filings/0001386570-26-000031.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-26-000031 |
| 2026-05-06 | 16:01 ET | [10-Q](/filings/0001386570-26-000030.md) | Quarterly report, period 2026-03-31 | 0001386570-26-000030 |
| 2026-04-29 | 16:02 ET | [DEF 14A](/filings/0001386570-26-000022.md) | Proxy statement, period 2026-06-24 | 0001386570-26-000022 |
| 2026-03-19 | 08:34 ET | [8-K](/filings/0001386570-26-000017.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001386570-26-000017 |
| 2026-03-04 | 16:01 ET | [8-K](/filings/0001386570-26-000014.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-26-000014 |
| 2026-03-04 | 16:01 ET | [10-K](/filings/0001386570-26-000013.md) | Annual report, period 2025-12-31 | 0001386570-26-000013 |
| 2026-02-26 | 07:02 ET | [8-K](/filings/0001386570-26-000003.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001386570-26-000003 |
| 2025-12-22 | 08:32 ET | [8-K](/filings/0001386570-25-000030.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-25-000030 |
| 2025-11-06 | 09:05 ET | [8-K](/filings/0001386570-25-000025.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001386570-25-000025 |
| 2025-11-04 | 16:01 ET | [8-K](/filings/0001386570-25-000021.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-25-000021 |
| 2025-11-04 | 16:01 ET | [10-Q](/filings/0001386570-25-000020.md) | Quarterly report, period 2025-09-30 | 0001386570-25-000020 |
| 2025-10-06 | 16:04 ET | [8-K](/filings/0001386570-25-000015.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-25-000015 |
| 2025-08-06 | 16:06 ET | [8-K](/filings/0001386570-25-000011.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001386570-25-000011 |
| 2025-08-06 | 16:05 ET | [10-Q](/filings/0001386570-25-000010.md) | Quarterly report, period 2025-06-30 | 0001386570-25-000010 |
| 2025-07-29 | 16:54 ET | [8-K](/filings/0001628280-25-036445.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-036445 |
| 2025-06-27 | 16:03 ET | [8-K](/filings/0001628280-25-033302.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-033302 |
| 2025-05-07 | 16:01 ET | [8-K](/filings/0001628280-25-023129.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-023129 |
| 2025-05-07 | 16:01 ET | [10-Q](/filings/0001628280-25-023127.md) | Quarterly report, period 2025-03-31 | 0001628280-25-023127 |
| 2025-04-29 | 16:18 ET | [DEF 14A](/filings/0001628280-25-020690.md) | Proxy statement, period 2024-12-31 | 0001628280-25-020690 |
| 2025-03-19 | 08:32 ET | [8-K](/filings/0001628280-25-013681.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-013681 |
| 2025-03-04 | 16:02 ET | [8-K](/filings/0001628280-25-009785.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-009785 |
| 2025-03-04 | 16:01 ET | [10-K](/filings/0001628280-25-009774.md) | Annual report, period 2024-12-31 | 0001628280-25-009774 |
| 2025-02-27 | 16:29 ET | [8-K](/filings/0001628280-25-008691.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-008691 |
| 2024-12-16 | 16:00 ET | [8-K](/filings/0001628280-24-051374.md) | 4.01 Change of auditor | 0001628280-24-051374 |
| 2024-12-04 | 17:26 ET | [8-K](/filings/0001628280-24-049951.md) | 8.01 Other events | 0001628280-24-049951 |
| 2024-11-21 | 16:01 ET | [8-K](/filings/0001628280-24-048830.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-24-048830 |
| 2024-10-31 | 16:01 ET | [8-K](/filings/0001628280-24-044541.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-044541 |
| 2024-10-31 | 16:00 ET | [10-Q](/filings/0001628280-24-044540.md) | Quarterly report, period 2024-09-30 | 0001628280-24-044540 |
| 2024-10-11 | 16:00 ET | [8-K](/filings/0001628280-24-042724.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001628280-24-042724 |
| 2024-09-20 | 08:32 ET | [8-K](/filings/0001628280-24-040982.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-040982 |
| 2024-08-21 | 06:06 ET | [SC 13D/A](/filings/0001193125-24-204003.md) | Ownership report, active investor, amended | 0001193125-24-204003 |
| 2024-08-21 | 06:05 ET | [SC 13D/A](/filings/0001193125-24-204002.md) | Ownership report, active investor, amended | 0001193125-24-204002 |
| 2024-08-07 | 16:02 ET | [8-K](/filings/0001628280-24-035593.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-035593 |
| 2024-08-07 | 16:01 ET | [10-Q](/filings/0001628280-24-035591.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035591 |
| 2024-07-16 | 16:00 ET | [8-K](/filings/0001628280-24-031955.md) | 5.02 Departure or appointment of officers or directors | 0001628280-24-031955 |
| 2024-06-25 | 17:18 ET | [8-K](/filings/0001628280-24-029936.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-029936 |
| 2024-06-24 | 17:28 ET | [8-K](/filings/0001628280-24-029643.md) | 5.07 Shareholder vote results | 0001628280-24-029643 |
| 2024-05-08 | 16:02 ET | [8-K](/filings/0001628280-24-021648.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-021648 |
| 2024-05-08 | 16:01 ET | [10-Q](/filings/0001628280-24-021645.md) | Quarterly report, period 2024-03-31 | 0001628280-24-021645 |
| 2024-04-25 | 16:01 ET | [DEF 14A](/filings/0001628280-24-018138.md) | Proxy statement, period 2024-04-25 | 0001628280-24-018138 |
| 2024-03-06 | 16:02 ET | [8-K](/filings/0001628280-24-009383.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-009383 |
| 2024-03-06 | 16:01 ET | [10-K](/filings/0001628280-24-009380.md) | Annual report, period 2023-12-31 | 0001628280-24-009380 |
| 2023-12-13 | 16:00 ET | [8-K](/filings/0001628280-23-041428.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-23-041428 |
| 2023-11-08 | 16:02 ET | [8-K](/filings/0001628280-23-037816.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-037816 |
| 2023-11-08 | 16:01 ET | [10-Q](/filings/0001628280-23-037809.md) | Quarterly report, period 2023-09-30 | 0001628280-23-037809 |
| 2023-09-07 | 06:20 ET | [SC 13D/A](/filings/0001193125-23-230038.md) | Ownership report, active investor, amended | 0001193125-23-230038 |
| 2023-08-09 | 16:02 ET | [8-K](/filings/0001628280-23-028555.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-028555 |

Page 1 of 8. [Older](/companies/nage/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.